Security key
75629V104
RECURSION PHARMACEUTICALS, INC. - COMMON STOCK (RXRX)
CUSIP: 75629V104
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 106,463,853
- Total 13F value
- $861,094,172
- Share change
- +11,625,285
- Put/Call ratio
- 76%
- SEC-reported price per share
- $8.14
- Number of holders
- 130
- Value change
- +$96,496,440
- Number of buys
- 72
- Number of sells
- 52
- Shares outstanding
- 525,850,455
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2022
Institutions
130
Top holders
10
RXRX full security history
Ownership snapshot
Full 13F holder table
RECURSION PHARMACEUTICALS, INC. SEC filings
RECURSION PHARMACEUTICALS, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of RXRX - RECURSION PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Lux Ventures IV, L.P.
Disclosed value leader
BAILLIE GIFFORD & CO
Comparable rows
0/15
Latest evidence
31 Mar 2022
3/4/5
13F
Highest disclosed value: $833,431,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BAILLIE GIFFORD & CO has the largest disclosed position value at $833.43M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAILLIE GIFFORD & CO's linked filing trail.
Disclosed position value
Top 5
Lux Ventures IV, L.P.
$137.71M
MIC Capital Partners (Public) Par...
$14.69M
BAILLIE GIFFORD & CO
$833.43M
GENERAL ATLANTIC, L.P.
$365.97M
ARK Investment Management LLC
$280.31M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Lux Ventures IV, L.P. |
3/4/5
Former 10% Owner
|
—
denominator unverified
|
$137,710,376
13,021,519 shares
|
— | 07 Dec 2021 |
| MIC Capital Partners (Public) Parallel Cayman, LP |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$14,688,335
1,388,889 shares
|
— | 01 Nov 2021 |
| BAILLIE GIFFORD & CO |
13F
Company
|
—
mixed-class rows
|
$833,431,000
189,734,284 shares
mixed-class rows
|
— | 31 Mar 2022 |
| GENERAL ATLANTIC, L.P. |
13F
Company
|
—
denominator unverified
|
$365,968,000
90,810,814 shares
|
— | 31 Mar 2022 |
| ARK Investment Management LLC |
13F
Company
|
—
mixed-class rows
|
$280,313,000
67,360,803 shares
mixed-class rows
|
— | 31 Mar 2022 |
| Anchorage Capital Group, L.L.C. |
13F
Company
|
—
denominator unverified
|
$278,708,000
69,158,354 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
130
Shares
106,463,853
Rows available
130
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
124
Q2 2022 holders
130
Holder diff
6
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|